Surber B[au] - Search Results

Year	Number of Results
1991	1
1994	3
1995	2
1996	1
1997	2
1998	1
1999	2
2001	1
2004	2
2005	3
2006	2
2007	2
2008	3
2009	2
2011	1
2012	1
2015	1
2016	1
2021	1
2024	0

1

Synthesis of [H-3]- and [C-14]-labeled elagolix.

Soli ED, Surber BW, Reed AD. Soli ED, et al. Among authors: surber bw. J Labelled Comp Radiopharm. 2021 Jun 15;64(7):254-261. doi: 10.1002/jlcr.3908. Epub 2021 Mar 22. J Labelled Comp Radiopharm. 2021. PMID: 33675109

2

Metabolism and Disposition of Pan-Genotypic Inhibitor of Hepatitis C Virus NS5A Ombitasvir in Humans.

Shen J, Serby M, Surber B, Lee AJ, Ma J, Badri P, Menon R, Kavetskaia O, de Morais SM, Sydor J, Fischer V. Shen J, et al. Among authors: surber b. Drug Metab Dispos. 2016 Aug;44(8):1148-57. doi: 10.1124/dmd.115.067496. Epub 2016 May 13. Drug Metab Dispos. 2016. PMID: 27179128

3

[O-ethyl 14C]phenacetin O-deethylase activity in human liver microsomes.

Rodrigues AD, Surber BW, Yao Y, Wong SL, Roberts EM. Rodrigues AD, et al. Among authors: surber bw. Drug Metab Dispos. 1997 Sep;25(9):1097-100. Drug Metab Dispos. 1997. PMID: 9311627

4

A (14)C-leucine absorption, distribution, metabolism and excretion (ADME) study in adult Sprague-Dawley rat reveals β-hydroxy-β-methylbutyrate as a metabolite.

Lee AJ, Beno DW, Zhang X, Shapiro R, Mason M, Mason-Bright T, Surber B, Edens NK. Lee AJ, et al. Among authors: surber b. Amino Acids. 2015 May;47(5):917-24. doi: 10.1007/s00726-015-1920-6. Epub 2015 Jan 25. Amino Acids. 2015. PMID: 25618754 Free PMC article.

5

[3H]A-804598 ([3H]2-cyano-1-[(1S)-1-phenylethyl]-3-quinolin-5-ylguanidine) is a novel, potent, and selective antagonist radioligand for P2X7 receptors.

Donnelly-Roberts DL, Namovic MT, Surber B, Vaidyanathan SX, Perez-Medrano A, Wang Y, Carroll WA, Jarvis MF. Donnelly-Roberts DL, et al. Among authors: surber b. Neuropharmacology. 2009 Jan;56(1):223-9. doi: 10.1016/j.neuropharm.2008.06.012. Epub 2008 Jun 17. Neuropharmacology. 2009. PMID: 18602931

6

Iniparib nonselectively modifies cysteine-containing proteins in tumor cells and is not a bona fide PARP inhibitor.

Liu X, Shi Y, Maag DX, Palma JP, Patterson MJ, Ellis PA, Surber BW, Ready DB, Soni NB, Ladror US, Xu AJ, Iyer R, Harlan JE, Solomon LR, Donawho CK, Penning TD, Johnson EF, Shoemaker AR. Liu X, et al. Among authors: surber bw. Clin Cancer Res. 2012 Jan 15;18(2):510-23. doi: 10.1158/1078-0432.CCR-11-1973. Epub 2011 Nov 29. Clin Cancer Res. 2012. PMID: 22128301

7

[3H]A-585539 [(1S,4S)-2,2-dimethyl-5-(6-phenylpyridazin-3-yl)-5-aza-2-azoniabicyclo[2.2.1]heptane], a novel high-affinity alpha7 neuronal nicotinic receptor agonist: radioligand binding characterization to rat and human brain.

Anderson DJ, Bunnelle W, Surber B, Du J, Surowy C, Tribollet E, Marguerat A, Bertrand D, Gopalakrishnan M. Anderson DJ, et al. Among authors: surber b. J Pharmacol Exp Ther. 2008 Jan;324(1):179-87. doi: 10.1124/jpet.107.130062. Epub 2007 Oct 24. J Pharmacol Exp Ther. 2008. PMID: 17959745

8

Metabolism and disposition of the HIV-1 protease inhibitor ritonavir (ABT-538) in rats, dogs, and humans.

Denissen JF, Grabowski BA, Johnson MK, Buko AM, Kempf DJ, Thomas SB, Surber BW. Denissen JF, et al. Among authors: surber bw. Drug Metab Dispos. 1997 Apr;25(4):489-501. Drug Metab Dispos. 1997. PMID: 9107549

9

Use of an inverse agonist radioligand [3H]A-317920 reveals distinct pharmacological profiles of the rat histamine H3 receptor.

Yao BB, Witte DG, Miller TR, Carr TL, Kang CH, Cassar S, Faghih R, Bennani YL, Surber BW, Hancock AA, Esbenshade TA. Yao BB, et al. Among authors: surber bw. Neuropharmacology. 2006 Mar;50(4):468-78. doi: 10.1016/j.neuropharm.2005.10.008. Epub 2005 Nov 28. Neuropharmacology. 2006. PMID: 16316670

10

Potent inhibition of the cytochrome P-450 3A-mediated human liver microsomal metabolism of a novel HIV protease inhibitor by ritonavir: A positive drug-drug interaction.

Kumar GN, Dykstra J, Roberts EM, Jayanti VK, Hickman D, Uchic J, Yao Y, Surber B, Thomas S, Granneman GR. Kumar GN, et al. Among authors: surber b. Drug Metab Dispos. 1999 Aug;27(8):902-8. Drug Metab Dispos. 1999. PMID: 10421617

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

28 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

28 results

Results by year